Skip Nav Destination
Contributions to Oncology
International Vinca Alkaloid Symposium - Vindesine: ProceedingsAvailable to Purchase
Edited by
S.Karger AG
Volume
6
Status:
Available
ISBN electronic:
978-3-318-03389-2
ISBN print:
978-3-8055-2501-5
Discontinued Book Series:
Contributions to Oncology
Publication date:
1981
International Vinca Alkaloid Symposium - Vindesine: Proceedings
Edited by: W. Brade, G.A. Nagel, S. Seeber
https://doi.org/10.1159/isbn.978-3-318-03389-2
ISBN (print): 978-3-8055-2501-5
ISBN (electronic): 978-3-318-03389-2
Publisher: S.Karger AG
Published: 1981
Download citation file:
Digital Version
Pay-Per-View Access
$116.00
Print Version
International Vinca Alkaloid Symposium - Vindesine
$116.00
Table of Contents
-
2 - 6: Comparative Effects of Vindesine, Vincristine and Vinblastine on Tubular Formations in Electron MicroscopyByM. Paintrand;M. PaintrandHôpital Paul-Brousse: Institut de Cancérologie et d’Immunogénétique (INSERM U-50), VillejuifSearch for other works by this author on:I. Pignot;I. PignotHôpital Paul-Brousse: Institut de Cancérologie et d’Immunogénétique (INSERM U-50), VillejuifSearch for other works by this author on:D. Dantchev;D. DantchevHôpital Paul-Brousse: Institut de Cancérologie et d’Immunogénétique (INSERM U-50), VillejuifSearch for other works by this author on:R. MaralR. MaralHôpital Paul-Brousse: Institut de Cancérologie et d’Immunogénétique (INSERM U-50), VillejuifSearch for other works by this author on:
-
7 - 15: Anti-Invasive Effect of Vinca Alkaloids in Vitro: Ultrastructural Aspects and Reversibility1ByG. Storme;G. StormeLaboratory of Experimental Cancerology, Department of Radiotherapy and Nuclear Medicine, Academic Hospital, Gent, BelgiumSearch for other works by this author on:M. Mareel;M. MareelLaboratory of Experimental Cancerology, Department of Radiotherapy and Nuclear Medicine, Academic Hospital, Gent, BelgiumSearch for other works by this author on:G. de Bruyne;G. de BruyneLaboratory of Experimental Cancerology, Department of Radiotherapy and Nuclear Medicine, Academic Hospital, Gent, BelgiumSearch for other works by this author on:R. van CauwenbergeR. van CauwenbergeLaboratory of Experimental Cancerology, Department of Radiotherapy and Nuclear Medicine, Academic Hospital, Gent, BelgiumSearch for other works by this author on:
-
16 - 26: Effects of Vinca Alkaloids on Calmodulin-Dependent Ca2+-Transport ATPaseByKlaus Gietzen;Klaus Gietzen1Department of Pharmacology and Toxicology, University of Ulm, Ulm, German Federal RepublicSearch for other works by this author on:Andreas Wüthrich;Andreas Wüthrich2Department of Veterinary Pharmacology, University of Bern, Bern, SwitzerlandSearch for other works by this author on:Angela Mansard;Angela Mansard1Department of Pharmacology and Toxicology, University of Ulm, Ulm, German Federal RepublicSearch for other works by this author on:Hermann BaderHermann Bader1Department of Pharmacology and Toxicology, University of Ulm, Ulm, German Federal RepublicSearch for other works by this author on:
-
27 - 36: Effects of Vinca Alkaloids on Cyclic AMP Metabolism of Mouse Splenic Lymphocytes1ByJ. R. SheppardJ. R. SheppardDight Institute for Human Genetics, University of Minnesota, Minneapolis, MinnesotaSearch for other works by this author on:
-
37 - 42: Patterns of Cross-Resistance of Vinca AlkaloidsByS. SeeberS. SeeberInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, EssenSearch for other works by this author on:
-
43 - 52: In Vitro and in Vivo Studies on Possible Mutagenic Effects of the Vinca Alkaloid Vindesine SulfateByG. Röhrborn;G. RöhrbornDepartment of Human Genetics and Anthropology University of DüsseldorfSearch for other works by this author on:A. BaslerA. BaslerDepartment of Human Genetics and Anthropology University of DüsseldorfSearch for other works by this author on:
-
53 - 58: In Vitro Phase II Trial of Vinca Alkaloids1ByStephen E. Jones;Stephen E. JonesUniversity of Arizona, Cancer Center, Tucson, ArizonaSearch for other works by this author on:Sydney E. Salmon;Sydney E. SalmonUniversity of Arizona, Cancer Center, Tucson, ArizonaSearch for other works by this author on:David S. Alberts;David S. AlbertsUniversity of Arizona, Cancer Center, Tucson, ArizonaSearch for other works by this author on:Frank L. Meyskens;Frank L. MeyskensUniversity of Arizona, Cancer Center, Tucson, ArizonaSearch for other works by this author on:Brian G. M. Durie;Brian G. M. DurieUniversity of Arizona, Cancer Center, Tucson, ArizonaSearch for other works by this author on:H.-S. G. ChenH.-S. G. ChenUniversity of Arizona, Cancer Center, Tucson, ArizonaSearch for other works by this author on:
-
72 - 77: Vindesine 24-h Infusion. Phase I StudyByW. Weber;W. Weber1Division of Oncology, Department of MedicineSearch for other works by this author on:W. Tackmann;W. Tackmann2Department of Neurology, University of Basel, Kantonsspital, BaselSearch for other works by this author on:C. Ludwig;C. Ludwig1Division of Oncology, Department of MedicineSearch for other works by this author on:R. Egger;R. Egger1Division of Oncology, Department of MedicineSearch for other works by this author on:J. P. ObrechtJ. P. Obrecht1Division of Oncology, Department of MedicineSearch for other works by this author on:
-
78 - 83: A Study of the Toxicity of Vindesine in Continuous Infusion over Five DaysByM. Beer;M. BeerServizio Oncologico, Ospedale San Giovanni, BellinzonaSearch for other works by this author on:M. Varini;M. VariniServizio Oncologico, Ospedale San Giovanni, BellinzonaSearch for other works by this author on:F. CavalliF. CavalliServizio Oncologico, Ospedale San Giovanni, BellinzonaSearch for other works by this author on:
-
84 - 91: Vindesine in the Therapy of Solid TumorsByGerald P. Bodey;Gerald P. BodeyFrom the Department of Developmental Therapeutics, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TexasSearch for other works by this author on:Manuel Valdivieso;Manuel ValdiviesoFrom the Department of Developmental Therapeutics, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TexasSearch for other works by this author on:Agop Y. Bedikian;Agop Y. BedikianFrom the Department of Developmental Therapeutics, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TexasSearch for other works by this author on:Boh-Seng Yap;Boh-Seng YapFrom the Department of Developmental Therapeutics, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TexasSearch for other works by this author on:Emil J. FreireichEmil J. FreireichFrom the Department of Developmental Therapeutics, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TexasSearch for other works by this author on:
-
92 - 94: Summary of Discussion to Papers under I
-
95 - 123: Critical Review of Pharmacology, Toxicology, Pharmacokinetics of Vincristine, Vindesine, VinblastineByW. P. BradeW. P. BradeMedizinisch- Wissenschaftliche Abteilung der Eli Lilly GmbH, Bad HomburgSearch for other works by this author on:
-
126 - 133: Long-Term Administration of Vindesine in Maintenance Regimen for Acute Lymphoblastic Leukemia (ALL) with Poor Prognosis. Apparent Lack of Long-Term Cumulative NeurotoxicityByJ. L. Misset;J. L. MissetInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:G. Mathé;G. MathéInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:F. de Vassal;F. de VassalInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:M. Delgado;M. DelgadoInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:M. Musset;M. MussetInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:S. Metral;S. MetralInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:A. Ropert;A. RopertInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:L. Schwarzenberg;L. SchwarzenbergInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:C. Jasmin;C. JasminInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:D. Machover;D. MachoverInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:P. Ribaud;P. RibaudInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:T. Dorval;T. DorvalInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:M. BayatM. BayatInst. de Cancérologie et d’Immunogénétique, Hôpital Paul Brousse, Villejuif CedexSearch for other works by this author on:
-
134 - 142: Phase II Trial with Vindesine in Patients with Hematologic Malignancies, Mainly in Blastic Crisis of Chronic Myelogenous LeukemiaByR. Engelhardt;R. EngelhardtMedizinische Universitätsklinik, FreiburgSearch for other works by this author on:K. Bross;K. BrossMedizinische Universitätsklinik, FreiburgSearch for other works by this author on:M. Weber;M. WeberMedizinische Universitätsklinik, FreiburgSearch for other works by this author on:W. Möbius;W. MöbiusMedizinische Universitätsklinik, FreiburgSearch for other works by this author on:G. W. LöhrG. W. LöhrMedizinische Universitätsklinik, FreiburgSearch for other works by this author on:
-
143 - 150: Vindesine and Prednisone in the Treatment of Relapsed Lymphomalignancies, Blastic Crisis of Chronic Myelocytic Leukemia and Acute Myelomonocytic LeukemiaByR. Hulhoven;R. HulhovenDepartment of Hematology, Cliniques St-Luc, Catholic University of Louvain, Avenue Hippocrate 10, BrusselsSearch for other works by this author on:J. L. Michaux;J. L. MichauxDepartment of Hematology, Cliniques St-Luc, Catholic University of Louvain, Avenue Hippocrate 10, BrusselsSearch for other works by this author on:G. Cornu;G. CornuDepartment of Hematology, Cliniques St-Luc, Catholic University of Louvain, Avenue Hippocrate 10, BrusselsSearch for other works by this author on:A. Ferrant;A. FerrantDepartment of Hematology, Cliniques St-Luc, Catholic University of Louvain, Avenue Hippocrate 10, BrusselsSearch for other works by this author on:M. Symann;M. SymannDepartment of Hematology, Cliniques St-Luc, Catholic University of Louvain, Avenue Hippocrate 10, BrusselsSearch for other works by this author on:A. Bosly;A. BoslyDepartment of Hematology, Cliniques St-Luc, Catholic University of Louvain, Avenue Hippocrate 10, BrusselsSearch for other works by this author on:A. Delannoy;A. DelannoyDepartment of Hematology, Cliniques St-Luc, Catholic University of Louvain, Avenue Hippocrate 10, BrusselsSearch for other works by this author on:M. C. Dutrieux-Fauchet;M. C. Dutrieux-FauchetDepartment of Hematology, Cliniques St-Luc, Catholic University of Louvain, Avenue Hippocrate 10, BrusselsSearch for other works by this author on:G. SokalG. SokalDepartment of Hematology, Cliniques St-Luc, Catholic University of Louvain, Avenue Hippocrate 10, BrusselsSearch for other works by this author on:
-
156 - 158: Summary of Discussion to Papers under IIByV. DiehlV. DiehlMünchen and HannoverSearch for other works by this author on:
-
159 - 170: Treatment of Leukemias and Malignant Lymphomas with Vinca Alkaloids, with Special Reference to Vindesine — A Critical ReviewByK. P. HellriegelK. P. HellriegelDepartment of Internal Medicine, University of Cologne, CologneSearch for other works by this author on:
-
172 - 175: Vindesine in Breast Cancer and LymphomasByW. W. ten Bokkel Huinink;W. W. ten Bokkel HuininkThe Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, AmsterdamSearch for other works by this author on:E. Hamersma-van der Linden;E. Hamersma-van der LindenThe Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, AmsterdamSearch for other works by this author on:F. J. CletonF. J. CletonThe Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, AmsterdamSearch for other works by this author on:
-
176 - 177: Vindesine, a Phase II Study in Patients with Refractory Metastatic Breast Cancer1ByM. A. Cobleigh;M. A. CobleighIndiana University, Indianapolis, IndianaSearch for other works by this author on:S. D. Williams;S. D. WilliamsIndiana University, Indianapolis, IndianaSearch for other works by this author on:L. H. EinhornL. H. EinhornIndiana University, Indianapolis, IndianaSearch for other works by this author on:
-
178 - 182: Protracted Infusion of Vinca Alkaloids in Patients with Metastasizing Breast Cancer and Renal Cancer
-
183 - 184: Clinical Experience with VindesineByH. GerhartzH. GerhartzDepartment of Hematology and Oncology, Klinikum Westend, Free University Berlin, BerlinSearch for other works by this author on:
-
185 - 187: A Control Randomised Trial Comparing Vindesine and Adriamycin with Vincristine and Adriamycin in the Treatment of Advanced Breast CarcinomaByI. E. Smith;I. E. SmithFrom the Royal Marsden Hospital Breast Units, London and Surrey and The Combined Breast Clinic, St. George’s Hospital, London.Search for other works by this author on:T. J. Powles;T. J. PowlesFrom the Royal Marsden Hospital Breast Units, London and Surrey and The Combined Breast Clinic, St. George’s Hospital, London.Search for other works by this author on:R. C. Coombes;R. C. CoombesFrom the Royal Marsden Hospital Breast Units, London and Surrey and The Combined Breast Clinic, St. George’s Hospital, London.Search for other works by this author on:H. T. Ford;H. T. FordFrom the Royal Marsden Hospital Breast Units, London and Surrey and The Combined Breast Clinic, St. George’s Hospital, London.Search for other works by this author on:J. -C. Gazet;J. -C. GazetFrom the Royal Marsden Hospital Breast Units, London and Surrey and The Combined Breast Clinic, St. George’s Hospital, London.Search for other works by this author on:C. L. Harmer;C. L. HarmerFrom the Royal Marsden Hospital Breast Units, London and Surrey and The Combined Breast Clinic, St. George’s Hospital, London.Search for other works by this author on:J. A. McKinnaJ. A. McKinnaFrom the Royal Marsden Hospital Breast Units, London and Surrey and The Combined Breast Clinic, St. George’s Hospital, London.Search for other works by this author on:
-
188 - 194: Treatment of Advanced Breast Cancer with Vindesine, Carmustine and Tamoxifen in Patients no Longer Responsive to Adriamycin, 5-Fluorouracil, Methotrexate and Cyclophosphamide CombinationsByW. Queiβer;W. Queiβer1Onkologisches Zentrum, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, MannheimSearch for other works by this author on:I. Voss;I. Voss1Onkologisches Zentrum, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, MannheimSearch for other works by this author on:B. Maβner;B. Maβner1Onkologisches Zentrum, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, MannheimSearch for other works by this author on:P. Drings;P. Drings2Sektion Onkologie, Thoraxchirurgische Klinik, Heidelberg-RohrbachSearch for other works by this author on:D. Fritze;D. Fritze3Medizinische Universitätsklinik HeidelbergSearch for other works by this author on:M. WesterhausenM. Westerhausen4Medizinische Klinik II, St. Johannes-Hospital, DuisburgSearch for other works by this author on:
-
195 - 200: Multicentre Cancer Chemotherapy Group — Advanced Breast StudyByM. F. SpittleM. F. Spittle(Chairman, Multicentre Cancer Chemotherapy Group) Radiotherapy Department, Middlesex Hospital, LondonSearch for other works by this author on:
-
201 - 202: Vindesine plus Cisplatin in Advanced Breast Cancer: A Pilot StudyByR. Paridaens;R. ParidaensInstitut Jules Bordet, Centre des Tumeurs de l’Université Libre de Bruxelles Service de Médecine, BruxellesSearch for other works by this author on:J. -C. Heuson;J. -C. HeusonInstitut Jules Bordet, Centre des Tumeurs de l’Université Libre de Bruxelles Service de Médecine, BruxellesSearch for other works by this author on:M. RozencweigM. RozencweigInstitut Jules Bordet, Centre des Tumeurs de l’Université Libre de Bruxelles Service de Médecine, BruxellesSearch for other works by this author on:
-
203 - 211: Continuous Infusion of Vindesine in Breast Carcinoma: Clinical and Pharmacology StudiesByGerald P. Bodey;Gerald P. Bodey1From The Department of Developmental TherapeuticsSearch for other works by this author on:Hwee Yong Yap;Hwee Yong Yap2Medicine,The University of Texas System Cancer Center M. D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TexasSearch for other works by this author on:George R. Blumenschein;George R. Blumenschein2Medicine,The University of Texas System Cancer Center M. D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TexasSearch for other works by this author on:Niramol Savaraj;Niramol Savaraj1From The Department of Developmental TherapeuticsSearch for other works by this author on:Ti Li LooTi Li Loo1From The Department of Developmental TherapeuticsSearch for other works by this author on:
-
212 - 213: Summary of Discussion to Papers under III.1ByH. -E. WanderH. -E. WanderDuisburg and GöttingenSearch for other works by this author on:
-
222 - 226: Vindesine in the Treatment of Advanced Solid Tumors. Experience with a Twice-Weekly Schedule.ByWalter U. Rhomberg;Walter U. Rhomberg1W. U. Rhomberg, Head, Dept. of Radiotherapy, Landeskrankenhaus, Feldkirch-AustriaSearch for other works by this author on:Eleonore MescheEleonore Mesche2E. Mesche, Dept. of Radiotherapy and Special Oncology, Medizin. Hochschule Hannover, HannoverSearch for other works by this author on:
-
227 - 231: Vindesine (VDS) in Padua and Milan: Very Preliminary DataByM. Fiorentino;M. Fiorentino1Divisione di Oncologia Medica, Ospedale Generale di PadovaSearch for other works by this author on:E. Ferrazzi;E. Ferrazzi1Divisione di Oncologia Medica, Ospedale Generale di PadovaSearch for other works by this author on:V. Zagonel;V. Zagonel1Divisione di Oncologia Medica, Ospedale Generale di PadovaSearch for other works by this author on:S. Monfardini;S. Monfardini2Istituto Nationale Tumori, MilanoSearch for other works by this author on:L. Castellani;L. Castellani2Istituto Nationale Tumori, MilanoSearch for other works by this author on:E. BajettaE. Bajetta2Istituto Nationale Tumori, MilanoSearch for other works by this author on:
-
232 - 238: Results of a Chemotherapy Trial of Squamous Cell Carcinoma of Head and Neck Regions with Methotrexate and VindesineByJ. -H. Beyer;J. -H. Beyer1Medical University Clinics, Department of Hematology/Oncology, GöttingenSearch for other works by this author on:H. W. von Heyden;H. W. von Heyden1Medical University Clinics, Department of Hematology/Oncology, GöttingenSearch for other works by this author on:M. SchröderM. Schröder2University Clinic of Oto — Rhino — Laryngology, GöttingenSearch for other works by this author on:
-
239 - 249: Vindesine-Prednisone Combination in Advanced Multiple Myeloma Resistant to Alkylating AgentsByO. A. van Dobbenburgh;O. A. van Dobbenburgh2Department of Internal Medicine, University of GroningenSearch for other works by this author on:Th. Ockhuizen;Th. Ockhuizen3Laboratory of ImmunochemistrySearch for other works by this author on:
-
250 - 255: Multiple Myeloma: Paraprotein Serum Levels before and after Vindesine TherapyByU. Kaboth;U. KabothMedizin. Univ.-Klinik, Abtlg. Hämatologie/Onkologie, GöttingenSearch for other works by this author on:J. -H. Beyer;J. -H. BeyerMedizin. Univ.-Klinik, Abtlg. Hämatologie/Onkologie, GöttingenSearch for other works by this author on:G. A. NagelG. A. NagelMedizin. Univ.-Klinik, Abtlg. Hämatologie/Onkologie, GöttingenSearch for other works by this author on:
-
256 - 260: Vinblastine-Bleomycin in Comparison with Vinblastine-Bleomycin-Cisplatin in Disseminated Testicular CancerByW. W. ten Bokkel Huinink;W. W. ten Bokkel HuininkThe Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, AmsterdamSearch for other works by this author on:W. van Waardenburg;W. van WaardenburgThe Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, AmsterdamSearch for other works by this author on:G. SimonettiG. SimonettiThe Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, AmsterdamSearch for other works by this author on:
-
261 - 266: Investigations on the Possible Role of Vindesine in Chemotherapy for Testicular TeratomasByS. Seeber;S. SeeberInnere Universitätsklinik und Poliklinik (Tumorforschung), West-German Tumor Center, EssenSearch for other works by this author on:K. Bremer;K. BremerInnere Universitätsklinik und Poliklinik (Tumorforschung), West-German Tumor Center, EssenSearch for other works by this author on:M. Higi;M. HigiInnere Universitätsklinik und Poliklinik (Tumorforschung), West-German Tumor Center, EssenSearch for other works by this author on:N. Niederle;N. NiederleInnere Universitätsklinik und Poliklinik (Tumorforschung), West-German Tumor Center, EssenSearch for other works by this author on:C. G. SchmidtC. G. SchmidtInnere Universitätsklinik und Poliklinik (Tumorforschung), West-German Tumor Center, EssenSearch for other works by this author on:
-
267 - 273: Initial Experience with a Combination of Cisplatin and Vindesine in Advanced Malignant MelanomaByP. Dodion;P. Dodion1Institut Jules Bordet, Service de Médecine et Laboratoire d’Investigation Clinique H. J. Tagnon, Centre des Tumeurs de l’Université Libre de Bruxelles, Brussels, BelgiumSearch for other works by this author on:F. Cavalli;F. Cavalli2Ospedale San Giovanni, Servizio de Oncologico, Bellinzona, Switzerland.Search for other works by this author on:J. Revuz;J. Revuz4Institut Henri Mondor, Créteil, France.Search for other works by this author on:D. Thomas;D. Thomas5EORTC Data Center, Brussels, BelgiumSearch for other works by this author on:M. RozencweigM. Rozencweig1Institut Jules Bordet, Service de Médecine et Laboratoire d’Investigation Clinique H. J. Tagnon, Centre des Tumeurs de l’Université Libre de Bruxelles, Brussels, BelgiumSearch for other works by this author on:
-
274 - 276: Vindesine Combination Therapy of Malignant MelanomaByA. WohlrabA. WohlrabIII. Medizin. Klinik, Klinikum Großhadern der Universität München, MünchenSearch for other works by this author on:
-
277 - 285: Cisplatin, Vindesine and Bleomycin Combination Chemotherapy for Esophageal Carcinoma1ByD. P. Kelsen;D. P. KelsenFrom the Solid Tumor Service, Department of Medicine, Thoracic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New YorkSearch for other works by this author on:Manjit Bains;Manjit BainsFrom the Solid Tumor Service, Department of Medicine, Thoracic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New YorkSearch for other works by this author on:Robert ChapmanRobert ChapmanFrom the Solid Tumor Service, Department of Medicine, Thoracic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New YorkSearch for other works by this author on:
-
289 - 312: Vindesine in Melanoma, Testicular Cancer, Head and Neck Cancer, Myeloma and Other Solid Tumors, Except Breast and Lung Cancer: a Critical ReviewByH. -J. SchmollH. -J. SchmollDept. of Medicine, Division of Hemato-Oncology, Medical School Hannover, HannoverSearch for other works by this author on:
-
314 - 319: Vindesine plus Cisplatin Chemotherapy in Recurrent and Primarily Resistant Small Cell Bronchogenic CarcinomaByN. Niederle;N. NiederleInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, EssenSearch for other works by this author on:W. Krischke;W. KrischkeInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, EssenSearch for other works by this author on:C. G. Schmidt;C. G. SchmidtInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, EssenSearch for other works by this author on:S. SeeberS. SeeberInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, EssenSearch for other works by this author on:
-
320 - 326: Vindesine plus Cyclophosphamide versus Vincristine plus Cyclophosphamide in Previously Untreated Small Cell Cancer of the Lung: Preliminary ReportByL. R. HolstiL. R. Holsti1Department of Pulmonary Diseases and of Radiotherapy and Oncology, Helsinki University Central Hospital, HelsinkiSearch for other works by this author on:
-
327 - 336: Vindesine in the Treatment of Lung Cancer — a ReviewByKell Østerlind;Kell ØsterlindDepartment of Chemotherapy R II-V, Finsen Institute, CopenhagenSearch for other works by this author on:P. Grundtvig Sørensen;P. Grundtvig SørensenDepartment of Chemotherapy R II-V, Finsen Institute, CopenhagenSearch for other works by this author on:Heine Høi HansenHeine Høi HansenDepartment of Chemotherapy R II-V, Finsen Institute, CopenhagenSearch for other works by this author on:
-
337 - 341: Treatment of Small Cell Lung Cancer with a Polychemotherapy Consisting of VP 16-213, Iphosphamide and VindesineByK. Havemann;K. Havemann(Marburg) (Heidelberg) (Göttingen) (Frankfurt) 1Zentrum für Innere Medizin, Abteilung Hämatologie/Onkologie, MarburgSearch for other works by this author on:
-
342 - 343: Vindesine: an Effective Phase II Agent in the Treatment of Non-Small Cell Lung CancerByB. Furnas;B. FurnasIndiana University, Indianapolis, IndianaSearch for other works by this author on:S. D. Williams;S. D. WilliamsIndiana University, Indianapolis, IndianaSearch for other works by this author on:M. A. Cobleigh;M. A. CobleighIndiana University, Indianapolis, IndianaSearch for other works by this author on:L. H. EinhornL. H. EinhornIndiana University, Indianapolis, IndianaSearch for other works by this author on:
-
344 - 349: Continuous Vindesine Infusion Therapy in Cases of Advanced Non-Small Cell Bronchogenic CarcinomaByH. P. Dirks;H. P. DirksKrankenhaus Rohrbach, Klinik für Thorax-Erkrankungen, HeidelbergSearch for other works by this author on:P. Drings;P. DringsKrankenhaus Rohrbach, Klinik für Thorax-Erkrankungen, HeidelbergSearch for other works by this author on:H. G. Manke;H. G. MankeKrankenhaus Rohrbach, Klinik für Thorax-Erkrankungen, HeidelbergSearch for other works by this author on:H. H. VollhaberH. H. VollhaberKrankenhaus Rohrbach, Klinik für Thorax-Erkrankungen, HeidelbergSearch for other works by this author on:
-
350 - 355: Clinical Trials of New Agents in Patients with Non-Small Cell Lung Cancer1ByEphraim S. Casper;Ephraim S. CasperMemorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, N. Y.Search for other works by this author on:Richard J. Gralla;Richard J. GrallaMemorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, N. Y.Search for other works by this author on:David P. Kelsen;David P. KelsenMemorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, N. Y.Search for other works by this author on:Robert A. Chapman;Robert A. ChapmanMemorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, N. Y.Search for other works by this author on:Mark B. Stoopler;Mark B. StooplerMemorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, N. Y.Search for other works by this author on:Garrett R. Lynch;Garrett R. LynchMemorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, N. Y.Search for other works by this author on:Robert B. GolbeyRobert B. GolbeyMemorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, N. Y.Search for other works by this author on:
-
363 - 367: Results of Postoperative Chemotherapy in Non-Small Cell CarcinomaByR. Hendricks;R. HendricksChirurgische Klinik der Städtischen Kliniken Duisburg Onkologischer Arbeitskreis Duisburg Arbeitsgruppe BronchialcarcinomSearch for other works by this author on:U. Ammedick;U. AmmedickChirurgische Klinik der Städtischen Kliniken Duisburg Onkologischer Arbeitskreis Duisburg Arbeitsgruppe BronchialcarcinomSearch for other works by this author on:H. Hirsch;H. HirschChirurgische Klinik der Städtischen Kliniken Duisburg Onkologischer Arbeitskreis Duisburg Arbeitsgruppe BronchialcarcinomSearch for other works by this author on:R. M. Konrad;R. M. KonradChirurgische Klinik der Städtischen Kliniken Duisburg Onkologischer Arbeitskreis Duisburg Arbeitsgruppe BronchialcarcinomSearch for other works by this author on:V. Rausch;V. RauschChirurgische Klinik der Städtischen Kliniken Duisburg Onkologischer Arbeitskreis Duisburg Arbeitsgruppe BronchialcarcinomSearch for other works by this author on:W. WellensW. WellensChirurgische Klinik der Städtischen Kliniken Duisburg Onkologischer Arbeitskreis Duisburg Arbeitsgruppe BronchialcarcinomSearch for other works by this author on:
-
368 - 370: The Results of Chemotherapy in Inoperable Non-Small Cell Bronchogenic CancerByW. Wellens;W. WellensOnkologischer Arbeitskreis Duisburg e. V. Working Group Lung Cancer Cooperating Institution: Städt. Kliniken Duisburg, Chir. Abt. Cooperating Institution: Ev. Krankenanstalten Duisburg-Nord, Chir. Abt. Cooperating Institution: Johanniter-Krankenhaus Oberhausen-Sterkrade, Innere Abt. Cooperating Institution: St. Johannes-Hospital, Med. Klinik II,Search for other works by this author on:M. Westerhausen;M. WesterhausenOnkologischer Arbeitskreis Duisburg e. V. Working Group Lung Cancer Cooperating Institution: Städt. Kliniken Duisburg, Chir. Abt. Cooperating Institution: Ev. Krankenanstalten Duisburg-Nord, Chir. Abt. Cooperating Institution: Johanniter-Krankenhaus Oberhausen-Sterkrade, Innere Abt. Cooperating Institution: St. Johannes-Hospital, Med. Klinik II,Search for other works by this author on:R. M. Konrad;R. M. KonradOnkologischer Arbeitskreis Duisburg e. V. Working Group Lung Cancer Cooperating Institution: Städt. Kliniken Duisburg, Chir. Abt. Cooperating Institution: Ev. Krankenanstalten Duisburg-Nord, Chir. Abt. Cooperating Institution: Johanniter-Krankenhaus Oberhausen-Sterkrade, Innere Abt. Cooperating Institution: St. Johannes-Hospital, Med. Klinik II,Search for other works by this author on:V. RauschV. RauschOnkologischer Arbeitskreis Duisburg e. V. Working Group Lung Cancer Cooperating Institution: Städt. Kliniken Duisburg, Chir. Abt. Cooperating Institution: Ev. Krankenanstalten Duisburg-Nord, Chir. Abt. Cooperating Institution: Johanniter-Krankenhaus Oberhausen-Sterkrade, Innere Abt. Cooperating Institution: St. Johannes-Hospital, Med. Klinik II,Search for other works by this author on:
-
386 - 391: Combination Chemotherapy with Vindesine + Cis-Platin versus VP-16 + Cis-Platin in Epidermoid Carcinoma of the Lung: A Preliminary ReportByL. R. Holsti;L. R. HolstiDepartment of Radiotherapy and Oncology, Department of Pulmonary Diseases, Helsinki University Central Hospital, HelsinkiSearch for other works by this author on:K. MattsonK. MattsonDepartment of Radiotherapy and Oncology, Department of Pulmonary Diseases, Helsinki University Central Hospital, HelsinkiSearch for other works by this author on:
-
392 - 397: Experience with the Combination of Cis-Platinum and Vindesine in the Treatment of Squamous Cell Carcinomas, Adenocarcinomas and Large Cell Bronchogenic CarcinomasByP. Bölcskei;P. Bölcskei13. Med. Klinik of the Städt. Klinikum NürnbergSearch for other works by this author on:H. Kleinfelder;H. Kleinfelder13. Med. Klinik of the Städt. Klinikum NürnbergSearch for other works by this author on:Z. Krasa;Z. Krasa2Thoraxchirurgische Klinik of the Bezirkskrankenhaus WöllersdorfSearch for other works by this author on:H. Mattausch;H. Mattausch2Thoraxchirurgische Klinik of the Bezirkskrankenhaus WöllersdorfSearch for other works by this author on:S. BeckhS. Beckh2Thoraxchirurgische Klinik of the Bezirkskrankenhaus WöllersdorfSearch for other works by this author on:
-
398 - 404: Vindesine versus Vindesine with Cis-Platinum in Metastatic Non-Small Cell Lung CancerByWaun K. Hong;Waun K. HongDepartment of Medicine and Radiology, Boston Veterans Administration Medical Center and University Hospital, Boston University School of Medicine, Boston (MA)Search for other works by this author on:Joseph Pennacchio;Joseph PennacchioDepartment of Medicine and Radiology, Boston Veterans Administration Medical Center and University Hospital, Boston University School of Medicine, Boston (MA)Search for other works by this author on:Robert Pugatch;Robert PugatchDepartment of Medicine and Radiology, Boston Veterans Administration Medical Center and University Hospital, Boston University School of Medicine, Boston (MA)Search for other works by this author on:John Krikorian;John KrikorianDepartment of Medicine and Radiology, Boston Veterans Administration Medical Center and University Hospital, Boston University School of Medicine, Boston (MA)Search for other works by this author on:Richard Bromer;Richard BromerDepartment of Medicine and Radiology, Boston Veterans Administration Medical Center and University Hospital, Boston University School of Medicine, Boston (MA)Search for other works by this author on:Jose Lopez;Jose LopezDepartment of Medicine and Radiology, Boston Veterans Administration Medical Center and University Hospital, Boston University School of Medicine, Boston (MA)Search for other works by this author on:L. Jack Faling;L. Jack FalingDepartment of Medicine and Radiology, Boston Veterans Administration Medical Center and University Hospital, Boston University School of Medicine, Boston (MA)Search for other works by this author on:Gordon SniderGordon SniderDepartment of Medicine and Radiology, Boston Veterans Administration Medical Center and University Hospital, Boston University School of Medicine, Boston (MA)Search for other works by this author on:
-
405 - 409: Chemotherapy of Inoperable Non-small Cell Carcinoma of the Lung with Vindesine, Cis-Platinum and Cyclophosphamide: A Pilot StudyByP. S. Mitrou;P. S. Mitrou1Department of Internal Medicine, Division of Hämatology, J. W. Goethe University, Frankfurt/M.Search for other works by this author on:M. Fischer;M. Fischer1Department of Internal Medicine, Division of Hämatology, J. W. Goethe University, Frankfurt/M.Search for other works by this author on:M. SchneiderM. Schneider2Department of Pathology, J. W. Goethe University, Frankfurt/M.Search for other works by this author on:
-
410 - 419: Cisplatin and Vindesine Based Combination Chemotherapy for Non-Small Cell Lung Cancer1: A Pilot StudyByD. P. Kelsen;D. P. KelsenFrom the Solid Tumor and Developmental Chemotherapy Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New YorkSearch for other works by this author on:R. Gralla;R. GrallaFrom the Solid Tumor and Developmental Chemotherapy Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New YorkSearch for other works by this author on:E. Casper;E. CasperFrom the Solid Tumor and Developmental Chemotherapy Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New YorkSearch for other works by this author on:R. GolbeyR. GolbeyFrom the Solid Tumor and Developmental Chemotherapy Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New YorkSearch for other works by this author on:
-
420 - 421: Summary of Discussion to Papers under III.3ByP. S. MitrouP. S. MitrouHeidelberg and FrankfurtSearch for other works by this author on:
-
422 - 429: Critical Review on the Use of Vindesine in the Treatment of Lung CancerByK. HavemannK. HavemannZentrum für Innere Medizin, Abteilung Hämatologie/Onkologie, Marburg, FRGSearch for other works by this author on:
-
443 - 447: V. SummaryByE. J. FreireichE. J. FreireichHouston/TexasSearch for other works by this author on:
